![Philip M. Sass](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Philip M. Sass
Consultant / Advisor at Ben Franklin Technology Partners /Ventures/
Philip M. Sass active positions
Companies | Position | Start | End |
---|---|---|---|
Ben Franklin Technology Partners /Ventures/
![]() Ben Franklin Technology Partners /Ventures/ Investment ManagersFinance Ben Franklin Technology Partners /Ventures/ (Ben Franklin Tech Partners) is a venture Capital firm founded in 1982. The firm is headquartered in Philadelphia, Pennsylvania. | Consultant / Advisor | - | - |
Career history of Philip M. Sass
Former positions of Philip M. Sass
Companies | Position | Start | End |
---|---|---|---|
University of Illinois | Corporate Officer/Principal | - | - |
Morphotek, Inc.
![]() Morphotek, Inc. Miscellaneous Commercial ServicesCommercial Services Morphotek, Inc. operates as a biotechnology company. It develops and distributes biopharmaceutical products. The firm leverages its Morphodoma and Libradoma platform technologies to develop and research a pipeline of preclinical and clinical stage monoclonal antibodies for the treatment of cancer, inflammation and infectious diseases. The company was founded by Nicholas C. Nicolaides, Luigi Grasso and Philip M. Sass in May 2000 and is headquartered in Exton, PA. | Chief Operating Officer | 01/05/2000 | - |
Founder | 23/02/2011 | - |
Training of Philip M. Sass
Indiana University | Doctorate Degree |
Statistics
International
United States | 5 |
Operational
Chief Operating Officer | 1 |
Founder | 1 |
Doctorate Degree | 1 |
Sectoral
Consumer Services | 3 |
Commercial Services | 2 |
Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Morphotek, Inc.
![]() Morphotek, Inc. Miscellaneous Commercial ServicesCommercial Services Morphotek, Inc. operates as a biotechnology company. It develops and distributes biopharmaceutical products. The firm leverages its Morphodoma and Libradoma platform technologies to develop and research a pipeline of preclinical and clinical stage monoclonal antibodies for the treatment of cancer, inflammation and infectious diseases. The company was founded by Nicholas C. Nicolaides, Luigi Grasso and Philip M. Sass in May 2000 and is headquartered in Exton, PA. | Commercial Services |
Ben Franklin Technology Partners /Ventures/
![]() Ben Franklin Technology Partners /Ventures/ Investment ManagersFinance Ben Franklin Technology Partners /Ventures/ (Ben Franklin Tech Partners) is a venture Capital firm founded in 1982. The firm is headquartered in Philadelphia, Pennsylvania. | Finance |
- Stock Market
- Insiders
- Philip M. Sass
- Experience